Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results

Princeton, New Jersey on August 7, 2026 - Soligenix, Inc. (Nasdaq: SNGX), a biopharmaceutical firm specializing in developing and marketing treatments for rare diseases with unmet medical requirements, shared its latest developments.